Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized, double blind, parallel group, repeat dose pharmacokinetic and pharmacodynamic study of four doses of ATL-962 (40mg, 80mg, 120mg, 240mg) in otherwise-healthy obese volunteers.

Trial Profile

Randomized, double blind, parallel group, repeat dose pharmacokinetic and pharmacodynamic study of four doses of ATL-962 (40mg, 80mg, 120mg, 240mg) in otherwise-healthy obese volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Aug 2011

At a glance

  • Drugs Cetilistat (Primary)
  • Indications Obesity
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 06 Sep 2006 Status change
    • 04 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top